Cargando…

Post-FDA Approval Results of Epithelium-Off, Full-Fluence, Dresden Protocol Corneal Collagen Crosslinking in the USA

INTRODUCTION: The purpose of this non-comparative, prospective, observational study was to evaluate the post-US Food and Drug Administration approval outcomes of epithelium-off, full-fluence, Dresden protocol corneal collagen crosslinking (CXL) for the treatment of progressive keratoconus (KCN) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ansah, Derick O., Wang, Jiangxia, Lu, Kevin, Jabbour, Samir, Bower, Kraig S., Soiberman, Uri S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708565/ https://www.ncbi.nlm.nih.gov/pubmed/33029700 http://dx.doi.org/10.1007/s40123-020-00306-1

Ejemplares similares

High-Fluence Accelerated Epithelium-Off Corneal Cross-Linking Protocol Provides Dresden Protocol–Like Corneal Strengthening
por: Abrishamchi, Reyhaneh, et al.
Publicado: (2021)

Crosslinking vs. Observation in Fellow Eyes of Keratoconus Patients
por: Li, Gavin, et al.
Publicado: (2022)

Hyperopic correction: clinical validation with epithelium-on and epithelium-off protocols, using variable fluence and topographically customized collagen corneal crosslinking
por: Kanellopoulos, Anastasios John, et al.
Publicado: (2014)

Transcriptomic and Immunohistochemical Analysis of Progressive Keratoconus Reveal Altered WNT10A in Epithelium and Bowman's Layer
por: Foster, James W., et al.
Publicado: (2021)

Progressive high-fluence epithelium-on accelerated corneal crosslinking: a novel corneal photodynamic therapy for early progressive keratoconus
por: Mazzotta, Cosimo, et al.
Publicado: (2023)

Diffuse lamellar keratitis after epi-off corneal crosslinking: An under-recognized complication?
por: Mannschreck, Diana B., et al.
Publicado: (2019)

Burst Pressures in Eyes with Clear Corneal Incisions Treated with ReSure Glue
por: Shehata, Ahmed E. M., et al.
Publicado: (2021)

The Safety Profile of FDA-Approved Epithelium-Off Corneal Cross-Linking in a US Community-Based Healthcare System
por: Ang, Michael J, et al.
Publicado: (2022)

Dresden concerti,
por: Vivaldi, Antonio, 1678-1741
Publicado: (1997)

Comparison of transepithelial corneal crosslinking with epithelium-off crosslinking (epithelium-off CXL) in adult Pakistani population with progressive keratoconus
por: Akbar, Bushra, et al.
Publicado: (2017)

Combined Protocols for Corneal Collagen Cross-Linking with Photorefractive Surgery for Refractive Management of Keratoconus: Update on Techniques and Review of Literature
por: Zhu, Angela Y., et al.
Publicado: (2019)

Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis
por: Li, Gavin, et al.
Publicado: (2020)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

The Correlation between Corneal Findings and Disease Severity in Keratoconus per Scheimpflug Corneal Tomography
por: Shehata, Ahmed E. M., et al.
Publicado: (2020)

Accelerators come into focus in Dresden
Publicado: (2014)

Epithelium-Off vs. transepithelial corneal collagen crosslinking in progressive keratoconus: 3 years of follow-up
por: Arance-Gil, Ángeles, et al.
Publicado: (2021)

Rate of Corneal Collagen Crosslinking Redo in Private Practice: Risk Factors and Safety
por: Antoun, Joelle, et al.
Publicado: (2015)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Dresden concerti. RV 170, 314a, 319, 341, 366 & 383 /
por: Vivaldi, Antonio, 1678-1741
Publicado: (1997)

Three-Year Outcomes of Implantable Collamer Lens Followed by Excimer Laser Enhancement (“Bioptics”) in the Treatment of High Myopic Astigmatism
por: Jabbour, Samir, et al.
Publicado: (2021)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

Keratoconus Management With Customized Photorefractive Keratectomy by Artificial Intelligence Ray-Tracing Optimization Combined With Higher Fluence Corneal Crosslinking: The Ray-Tracing Athens Protocol
por: Kanellopoulos, Anastasios John
Publicado: (2021)

Corneal collagen crosslinking in the treatment of infectious keratitis
por: Anwar, Hamed Mofeez, et al.
Publicado: (2011)

Crosslinker-free collagen gelation for corneal regeneration
por: Islam, Mohammad Mirazul, et al.
Publicado: (2022)

Safety, Efficacy, and Predictive Factors of Conventional Epithelium-Off Corneal Crosslinking in the Treatment of Progressive Keratoconus
por: Farhat, Rebecca, et al.
Publicado: (2020)

Porcelain Inlays as Made by Dr. Jenkins, of Dresden
por: Darby, Edwin T.
Publicado: (1899)

Letter from Dr. N. S. Jenkins, Dresden
por: Jenkins, N. S.
Publicado: (1899)

Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007)

FDA-Approved Natural Polymers for Fast Dissolving Tablets
por: Alam, Md Tausif, et al.
Publicado: (2014)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_77gpfaq8a50f0g8p8qavco9ch6